CN1177590C - 环磷酰胺包衣片剂 - Google Patents

环磷酰胺包衣片剂 Download PDF

Info

Publication number
CN1177590C
CN1177590C CNB998074330A CN99807433A CN1177590C CN 1177590 C CN1177590 C CN 1177590C CN B998074330 A CNB998074330 A CN B998074330A CN 99807433 A CN99807433 A CN 99807433A CN 1177590 C CN1177590 C CN 1177590C
Authority
CN
China
Prior art keywords
cyclophosphamide
expanded
talc
lactose monohydrate
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998074330A
Other languages
English (en)
Chinese (zh)
Other versions
CN1305381A (zh
Inventor
J
J·恩格尔
J·拉沃特
D·绍尔比尔
B·维彻特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Publication of CN1305381A publication Critical patent/CN1305381A/zh
Application granted granted Critical
Publication of CN1177590C publication Critical patent/CN1177590C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB998074330A 1998-06-15 1999-06-08 环磷酰胺包衣片剂 Expired - Fee Related CN1177590C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19826517.4 1998-06-15
DE19826517A DE19826517B4 (de) 1998-06-15 1998-06-15 Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette

Publications (2)

Publication Number Publication Date
CN1305381A CN1305381A (zh) 2001-07-25
CN1177590C true CN1177590C (zh) 2004-12-01

Family

ID=7870877

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998074330A Expired - Fee Related CN1177590C (zh) 1998-06-15 1999-06-08 环磷酰胺包衣片剂

Country Status (28)

Country Link
US (1) US20010046504A1 (enExample)
EP (1) EP1089739B1 (enExample)
JP (1) JP4891478B2 (enExample)
KR (1) KR100679872B1 (enExample)
CN (1) CN1177590C (enExample)
AR (1) AR019670A1 (enExample)
AT (1) ATE310523T1 (enExample)
AU (1) AU771284B2 (enExample)
BG (1) BG65253B1 (enExample)
BR (1) BR9911276A (enExample)
CA (1) CA2333682C (enExample)
CO (1) CO5070588A1 (enExample)
CZ (1) CZ302157B6 (enExample)
DE (3) DE19826517B4 (enExample)
DK (1) DK1089739T3 (enExample)
ES (1) ES2255276T3 (enExample)
HU (1) HU226528B1 (enExample)
IL (2) IL139944A0 (enExample)
NO (1) NO325154B1 (enExample)
NZ (1) NZ508888A (enExample)
PL (1) PL193398B1 (enExample)
RU (1) RU2236231C2 (enExample)
SK (1) SK286185B6 (enExample)
TR (1) TR200003702T2 (enExample)
TW (1) TWI242450B (enExample)
UA (1) UA75566C2 (enExample)
WO (1) WO1999065499A1 (enExample)
ZA (1) ZA200006998B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
ES2377729T3 (es) 2002-02-21 2012-03-30 Valeant International (Barbados) Srl Formulaciones de liberación modificada de al menos una forma de tramadol
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
JO3659B1 (ar) * 2010-06-02 2020-08-27 Astellas Deutschland Gmbh أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية
UA112170C2 (uk) 2010-12-10 2016-08-10 Санофі Протипухлинна комбінація, що містить антитіло, яке специфічно розпізнає cd38, і бортезоміб
EP2745833A1 (en) * 2012-12-21 2014-06-25 Institut Gustave Roussy Soluble, dispersible or orodispersible tablets comprising cyclophosphamide
US10016447B2 (en) 2014-09-26 2018-07-10 Intas Pharmaceuticals Ltd. Pharmaceutical composition having improved content uniformity
HRP20201405T1 (hr) 2016-03-17 2020-11-27 F. Hoffmann - La Roche Ag Derivat 5-etil-4-metil-pirazol-3-karboksamida, koji djeluje kao agonist taar-a

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
UA26305A (uk) * 1990-07-16 1999-08-30 Аста Медіка Аг Таблетка, спосіб її одержаhhя, граhулят та спосіб одержаhhя граhулята
DE59101431D1 (de) * 1990-07-16 1994-05-26 Asta Medica Ag Tablette und Granulat welche als Wirkstoff Mesna enthalten.
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
GB9115160D0 (en) * 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
GB9119983D0 (en) * 1991-09-19 1991-11-06 Erba Carlo Spa Dihydropyridine derivatives useful in antitumor therapy
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
JP3049095B2 (ja) * 1996-02-22 2000-06-05 サムジン ファーマシューチカル カンパニー，リミテッド 新規抗ウイルス性置換ピリミジンジオン単素炭素環式ヌクレオシド誘導体及びその製造方法とこれを活性成分として含有する組成物
JPH11322596A (ja) * 1998-05-12 1999-11-24 Shionogi & Co Ltd 白金錯体および環状リン酸エステルアミドを含有する抗癌剤
US20040034099A1 (en) * 2002-06-27 2004-02-19 Ramsey Beverly J. Pharmaceutical composition

Also Published As

Publication number Publication date
ZA200006998B (en) 2001-11-20
AR019670A1 (es) 2002-03-13
DK1089739T3 (da) 2006-04-03
SK18582000A3 (sk) 2001-08-06
DE59912829D1 (de) 2005-12-29
BG65253B1 (bg) 2007-10-31
NO20006325D0 (no) 2000-12-12
DE29921466U1 (de) 2000-03-09
JP2002518334A (ja) 2002-06-25
TR200003702T2 (tr) 2001-06-21
DE19826517A1 (de) 2000-03-02
CN1305381A (zh) 2001-07-25
PL193398B1 (pl) 2007-02-28
CO5070588A1 (es) 2001-08-28
ES2255276T3 (es) 2006-06-16
NO20006325L (no) 2000-12-12
RU2236231C2 (ru) 2004-09-20
KR20010052819A (ko) 2001-06-25
BR9911276A (pt) 2001-10-23
EP1089739B1 (de) 2005-11-23
CA2333682A1 (en) 1999-12-23
US20010046504A1 (en) 2001-11-29
AU771284B2 (en) 2004-03-18
WO1999065499A1 (de) 1999-12-23
JP4891478B2 (ja) 2012-03-07
UA75566C2 (en) 2006-05-15
HUP0102788A2 (hu) 2002-03-28
CA2333682C (en) 2008-01-29
IL139944A0 (en) 2002-02-10
PL344832A1 (en) 2001-11-19
NO325154B1 (no) 2008-02-11
DE19826517B4 (de) 2006-03-23
IL139944A (en) 2006-08-01
HK1037959A1 (en) 2002-03-01
NZ508888A (en) 2003-11-28
EP1089739A1 (de) 2001-04-11
AU4508599A (en) 2000-01-05
HU226528B1 (en) 2009-03-30
BG105139A (en) 2001-07-31
CZ302157B6 (cs) 2010-11-18
TWI242450B (en) 2005-11-01
ATE310523T1 (de) 2005-12-15
CZ20004489A3 (cs) 2001-08-15
SK286185B6 (sk) 2008-05-06
HUP0102788A3 (en) 2002-12-28
KR100679872B1 (ko) 2007-02-07

Similar Documents

Publication Publication Date Title
US6358525B1 (en) Sustained release polymer blend for pharmaceutical applications
US6217907B1 (en) Directly compressible high load acetaminophen formulations
US5662933A (en) Controlled release formulation (albuterol)
US6852336B2 (en) Directly compressible high load acetaminophen formulations
US6391337B2 (en) Directly compressible high load acetaminophen formulations
EP0157695A2 (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
WO2000040205A2 (en) Sustained release formulation with reduced moisture sensitivity
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
CN1177590C (zh) 环磷酰胺包衣片剂
EP2099432B1 (en) Method of forming a tablet comprising pre-blend of ibuprofen and silicon dioxide
EP1057479A1 (en) Pharmaceutical tablet formulations for direct compression
CN1867326A (zh) 加巴喷丁的缓释口服片剂及其制备方法
HK1037959B (en) Cyclophosphamide coated tablets
US20240350414A1 (en) Direct tableting auxiliary composition
IE921943A1 (en) Stabilized solid dosage forms of choline metal¹carboxymethylcellulose salicylate compositions.
JP2008214325A (ja) 固形製剤
WO2006025029A2 (en) Extended release composition of divalproex

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041201

Termination date: 20140608

EXPY Termination of patent right or utility model